Loading...
Linde plc
LIN•NASDAQ
Basic Materials
Chemicals - Specialty
$459.41
$-0.85(-0.18%)
Linde plc (LIN) Financial Performance & Income Statement Overview
Review Linde plc’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.46%
↑ 0.46%
Operating Income Growth
6.05%
↑ 6.05%
Net Income Growth
5.90%
↑ 5.90%
Operating Cash Flow Growth
1.27%
↑ 1.27%
Operating Margin
26.92%
↑ 26.92%
Gross Margin
27.47%
↑ 27.47%
Net Profit Margin
20.20%
↑ 20.20%
ROE
17.46%
↑ 17.46%
ROIC
12.54%
↑ 12.54%
Linde plc (LIN) Income Statement & Financial Overview
Review Linde plc's (LIN) income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $8.11B | $8.28B | $8.36B | $8.27B |
Cost of Revenue | $5.07B | $5.23B | $5.32B | $5.21B |
Gross Profit | $3.04B | $3.05B | $3.04B | $3.06B |
Gross Profit Ratio | $0.38 | $0.37 | $0.36 | $0.37 |
R&D Expenses | $38.00M | $39.00M | $37.00M | $36.00M |
SG&A Expenses | $786.00M | $814.00M | $823.00M | $840.00M |
Operating Expenses | $824.00M | $853.00M | $860.00M | $876.00M |
Total Costs & Expenses | $5.89B | $6.09B | $6.18B | $6.08B |
Interest Income | $29.00M | $0.00 | $5.00M | $0.00 |
Interest Expense | $0.00 | $232.00M | $0.00 | $72.00M |
Depreciation & Amortization | $910.00M | $913.00M | $960.00M | $958.00M |
EBITDA | $3.09B | $3.41B | $3.02B | $3.19B |
EBITDA Ratio | $0.38 | $0.41 | $0.36 | $0.39 |
Operating Income | $2.22B | $2.20B | $2.18B | $2.18B |
Operating Income Ratio | $0.27 | $0.27 | $0.26 | $0.26 |
Other Income/Expenses (Net) | -$3.00M | $106.00M | -$79.00M | $26.00M |
Income Before Tax | $2.22B | $2.30B | $2.10B | $2.21B |
Income Before Tax Ratio | $0.27 | $0.28 | $0.25 | $0.27 |
Income Tax Expense | $511.00M | $533.00M | $498.00M | $508.00M |
Net Income | $1.67B | $1.73B | $1.55B | $1.66B |
Net Income Ratio | $0.21 | $0.21 | $0.19 | $0.20 |
EPS | $3.53 | $3.60 | $3.24 | $3.46 |
Diluted EPS | $3.51 | $3.60 | $3.22 | $3.44 |
Weighted Avg Shares Outstanding | $473.30M | $475.87M | $477.66M | $479.97M |
Weighted Avg Shares Outstanding (Diluted) | $476.26M | $478.88M | $480.90M | $483.18M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan